Investigative Ophthalmology & Visual Science, Vol 38, 1922-1928, Copyright © 1997 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Transforming growth factor-beta receptor expression in human cornea

NC Joyce and JD Zieske
Schepens Eye Research Institute and the Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, USA.

PURPOSE: Limbal basal cells and corneal endothelial cells appear to be inhibited in the G1 phase of the cell cycle. As a preliminary to determining whether transforming growth factor-beta (TGF-beta) might mediate this inhibition, investigation was made to determine whether human corneal and limbal cells express TGF-beta receptor types I (RI), II (RII), and III (RIII). METHODS: Corneas from eight human donors, aged stillborn to 85 years, were fresh frozen, cryostat sectioned, and prepared for indirect immunofluorescence localization of RI, RII, and RIII, using an established protocol. Corneas from donors 50 years of age or older were used to prepare RNA from the epithelium and endothelium. Reverse transcription-polymerase chain reaction was conducted using primers specific for each TGF-beta receptor type. RESULTS: Immunolocalization patterns for RI, RII, and RIII were similar, regardless of donor age. Binding of RI and RII antibodies was barely detectable in central corneal epithelium; however, most limbal basal cells stained positively for RI and RII. All layers of central corneal epithelium and the suprabasal layers of the limbus stained positively for RIII, whereas staining for this receptor was markedly decreased in limbal basal cells. Corneal endothelium bound the antibody for all three TGF-beta receptor types. In the same tissue sections, antibody staining for the RIII protein was more intense in corneal endothelial cells than in limbal basal cells. Polymerase chain reaction product for RI, RII, and RIII was detected in the epithelium and in the endothelium. CONCLUSIONS: Limbal basal cells and corneal endothelial cells expressed mRNA and protein for TGF-beta receptor types I, II, and III, suggesting that both cell types can transmit a TGF-beta-induced signal. These two cell types may differ in their relative response to those TGF-beta isoforms that require binding to RIII for signal transduction, in that staining intensity for RIII was relatively low in limbal basal cells compared with that in the endothelium. That limbal basal and corneal endothelial cells express receptors for TGF-beta suggests that this cytokine could mediate G1 phase arrest in these two cell types.

This article has been cited by other articles:

				L. M. Carrington, J. Albon, I. Anderson, C. Kamma, and M. Boulton Differential Regulation of Key Stages in Early Corneal Wound Healing by TGF-{beta} Isoforms and Their Inhibitors Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1886 - 1894. [Abstract] [Full Text] [PDF]

				S. Saika, Y. Okada, T. Miyamoto, O. Yamanaka, Y. Ohnishi, A. Ooshima, C.-Y. Liu, D. Weng, and W. W.-Y. Kao Role of p38 MAP Kinase in Regulation of Cell Migration and Proliferation in Healing Corneal Epithelium Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 100 - 109. [Abstract] [Full Text] [PDF]

				S. C. Edmunds, D. P. Kelsell, J. L. Hungerford, and I. A. Cree Mutational Analysis of Selected Genes in the TGF{beta}, Wnt, pRb, and p53 Pathways in Primary Uveal Melanoma Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2845 - 2851. [Abstract] [Full Text] [PDF]

				N. C. Joyce, D. L. Harris, and D. M. Mello Mechanisms of Mitotic Inhibition in Corneal Endothelium: Contact Inhibition and TGF-{beta}2 Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2152 - 2159. [Abstract] [Full Text] [PDF]

				L. A. MacConell, A. M. O. Leal, and W. W. Vale The Distribution of Betaglycan Protein and mRNA in Rat Brain, Pituitary, and Gonads: Implications for a Role for Betaglycan in Inhibin-Mediated Reproductive Functions Endocrinology, March 1, 2002; 143(3): 1066 - 1075. [Abstract] [Full Text] [PDF]

				L. You and F. E. Kruse Differential Effect of Activin A and BMP-7 on Myofibroblast Differentiation and the Role of the Smad Signaling Pathway Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 72 - 81. [Abstract] [Full Text] [PDF]

				S. Hayashida-Hibino, H. Watanabe, K. Nishida, M. Tsujikawa, T. Tanaka, Y. Hori, Y. Saishin, and Y. Tano The Effect of TGF-{beta}1 on Differential Gene Expression Profiles in Human Corneal Epithelium Studied by cDNA Expression Array Invest. Ophthalmol. Vis. Sci., July 1, 2001; 42(8): 1691 - 1697. [Abstract] [Full Text] [PDF]

				J. D. Zieske, A. E. K. Hutcheon, X. Guo, E.-H. Chung, and N. C. Joyce TGF-{beta} Receptor Types I and II Are Differentially Expressed during Corneal Epithelial Wound Repair Invest. Ophthalmol. Vis. Sci., June 1, 2001; 42(7): 1465 - 1471. [Abstract] [Full Text]

				L. Reneker, D. Silversides, L Xu, and P. Overbeek Formation of corneal endothelium is essential for anterior segment development - a transgenic mouse model of anterior segment dysgenesis Development, January 2, 2000; 127(3): 533 - 542. [Abstract] [PDF]

				K.-H. Chen, D. L. Harris, and N. C. Joyce TGF-{beta}2 in Aqueous Humor Suppresses S-Phase Entry in Cultured Corneal Endothelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 1999; 40(11): 2513 - 2519. [Abstract] [Full Text] [PDF]